With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.4733-39-5,2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
General procedure: A mixture of (CBT)2Ir(m-Cl)2Ir(CBT)2 (0.84 g, 0.40 mmol) and1,10-phenanthroline (phen, 0.17 g, 0.84 mmol) in glycol (30 mL)wasstirred at 150 C in argon for 16 h. After being cooled to room temperature,an orange-red solution was obtained, and then 10 mLaqueous solution ofNH4PF6 (0.4 mol L1)was added in. The resultantorange floccules were filtered, washed withwater and then dried invacuum. The pure product was obtained by silica gel column chromatography,eluting with a mixture of CH2Cl2 and acetonitrile (10:1,volume ratio). Yield 90.3% (0.97 g, 0.72 mmol)
4733-39-5, The synthetic route of 4733-39-5 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Tang, Huaijun; Chen, Zeyu; Wei, Liying; Miao, Jingsheng; Meng, Guoyun; He, Yonghui; Wu, Hongbin; Dyes and Pigments; vol. 131; (2016); p. 340 – 348;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI